WilmerHale Reps Eko Devices in $5M Series A Round Led by ARTIS Ventures

WilmerHale Reps Eko Devices in $5M Series A Round Led by ARTIS Ventures

Firm News

Related Solutions

Helping clients launch their businesses and transform their innovative ideas into successful companies.
Advising life sciences innovators, investors and industry leaders on complex transactions, legal issues and business challenges.

On February 28, 2018, Eko Devices, a leader in acoustic cardiac monitoring, announced that it closed $5 million in Series A funding to grow its commercial team and to expand clinical studies on the use of its platform for valvular heart disease screening and heart failure monitoring. ARTIS Ventures led the round, with additional participation from Strategic Partners, DreamIt Ventures, 1812 Ventures, and FOUNDER.org.

WilmerHale's Joe Wyatt and Molly Holsinger represented Eko Devices in this transaction.

View Eko's full release about this announcement.

Notice

We appreciate your interest in WilmerHale. While we are pleased to have you contact us, please keep in mind that merely contacting WilmerHale does not create an attorney-client relationship. Such a relationship will not arise until the Firm agrees in writing to represent you in connection with a particular matter. Importantly, unless and until this has occurred, you should not provide us with any confidential information, and we have no duty to keep confidential any information that we may receive from you. Thank you for your understanding.

I Accept Cancel